US 7618632
Method of treating or ameliorating an immune cell associated pathology using GITR ligand antibodies
granted A61KA61K2039/505A61K38/00
Quick answer
US patent 7618632 (Method of treating or ameliorating an immune cell associated pathology using GITR ligand antibodies) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Nov 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as Represented by the Secretary of the Department of Health and Human Services
- Grant date
- Tue Nov 17 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61K, A61K2039/505, A61K38/00, A61P, A61P1/04